life sciences - Page 8 of 10 - Providence Business News

PURDUE PHARMA and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company related to the opioid epidemic for $10 billion to $12 billion. Who should receive the settlement money? / BLOOMBERG NEWS FILE PHOTO/GEORGE FEY

Who should be paid with settlement money from opioid medication producers?

This Week's Poll 08/30/2019

On Aug. 26 an Oklahoma judge ordered health care giant Johnson & Johnson to pay the state $572 million for costs incurred in the...

RUBIUS THERAPEUTICS reported a loss of $39.4 million in the second quarter of 2019. The company has yet to record revenue..4 million in the second quarter of 2019, The company is yet to have revenue.

Rubius reports $39.4M loss in Q2, heralds progress

Health Services 08/13/2019

PROVIDENCE – Rubius Therapeutics Inc. reported on Tuesday a loss of $39.4 million in the second quarter of 2019, or 50 cents per diluted...

IlluminOss breakthrough lands it in the biotech marketplace

Editorial and Op-Ed 03/01/2019

For years regional business and governmental leaders have been touting the potential here for breakthrough life sciences and biotechnology ventures. This week, one of...

RI BIO AND the Rhode Island BioHub Group’s collaborative report on the state’s life sciences industry indicated that the sector was held back by fragmented and uncoordinated resources. The report also recommended RI Bio as an organizing force among other suggestions intended to help the industry reach its potential in Rhode Island.

RI Bio, Rhode Island BioHub Group chart local life science industry...

Health Services 01/28/2019

PROVIDENCE — The state’s life sciences industry has been held back by fragmented and uncoordinated resources, according to a collaborative report from the biotechnology...

R.I. Hospital study investigates if drug can slow, improve Alzheimer’s symptoms

Health Services 01/21/2019

PROVIDENCE – Rhode Island Hospital researchers are seeking subjects for a Phase 2 study into whether an investigational drug, Troriluzole, a new version of...

THOMAS SEEWOESTER has replaced Tia Bush as Amgen's vice president of site operations for its Rhode Island and Woburn, Mass., facilities. Bush has taken on the role of senior vice president of quality at the company's headquarters in Thousand Oaks, Calif. / COURTESY AMGEN INC.

Seewoester replaces Bush as Amgen VP of site operations for R.I.,...

People 11/26/2018

PROVIDENCE – Tia Bush has moved on from her role as Amgen Inc.’s vice president of site operations, Rhode Island and Woburn, Mass., to...

RUBIUS THERAPEUTICS reported a $26.4 million loss for the third quarter. The company does not yet generate revenue.

Rubius reports $26.4M loss for Q3

Entrepreneurship 11/13/2018

PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...

AT THE CONSTRUCTION site of the Wexford Innovation Center in Providence are, from left, Dan Bagnall, project supervisor, Shawmut Design and Construction; Beverly Smith, client service manager, Shawmut; Sean Lee Burgo, project director for construction, Wexford Science & Technology; and Chi Yik, project manager, Shawmut. A parcel of land in the Interstate 195 Redevelopment District will be converted to temporary parking for tenants of the Wexford center, scheduled to open by June. / PBN FILE PHOTO/MICHAEL SALERNO

PBN on WJAR-TV, Nov. 12, 2018

Government 11/13/2018

Despite false starts, transformation of Jewelry District taking shape. Every week, PBN Editor Mark S. Murphy appears on WJAR-TV NBC 10’s Coffee Break to discuss...